Status:
RECRUITING
NextGen - Clinical Implication of Next Generation Sequencing
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Urinary Tract Infections
Eligibility:
FEMALE
18-80 years
Phase:
PHASE4
Brief Summary
Recently more advanced techniques, including Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) are available to detect bacteria in urine based on bacterial genomes. Comparing to tra...
Detailed Description
Bacterial sensitivity test for different antibiotics are the most important guide for treatment of patients with UTI. Unfortunately, for patients with less than 10,000 Colony Count (CC), usually no se...
Eligibility Criteria
Inclusion
- Female at least 18 years of age
- U/C (Urinary Culture) growth of \<10,000 Colony-Forming Units (CFU)
- Understanding and acceptance of the need to return for all scheduled follow-up visits
- Able to give informed consent
Exclusion
- Catheter in use (Foley or suprapubic or intermittent)
- Not able to provide clean midstream urine
- Antibiotic consumption in the past 2 weeks before signing the consent
- Pregnant or Planning to Conceive
- Incarcerated
Key Trial Info
Start Date :
May 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05206500
Start Date
May 17 2022
End Date
December 1 2028
Last Update
December 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Health Sciences
Winston-Salem, North Carolina, United States, 27157